secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001628280-24-047122
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeautyHealth Q3 net sales $78.8M (-19% YoY); adj. EBITDA $8.1M, revenue guidance cut, EBITDA raised
--------------------------------------------------------------------------------

- Q3 net sales $78.8M, down 19.1% YoY; delivery systems sales fell 46% to $27.6M, consumables up 10% to $51.2M.
- Net loss narrowed to $18.3M from $73.8M; GAAP gross margin improved to 51.6% from -12.9% YoY.
- Adjusted EBITDA $8.1M vs $9.1M; adjusted EBITDA margin 10.2% vs 9.3%.
- Full-year net sales guidance lowered; adjusted EBITDA guidance improved citing Q3 profitability.
- Centralized manufacturing in Long Beach by year-end, ending China partner relationship; new CRO and CMO hired.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000162828024047122/0001628280-24-047122-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000162828024047122/skin-20241112.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-047122

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer